Kiyatec 3D Predict MOA- Journal Ad

Kiyatec is a leader in functional precision oncology dedicated to revolutionizing cancer care. Their 3D Predict™ cell culture technology delivers patient-specific evidence of response to chemotherapy prior to treatment initiation. Knowing which therapy works before subjecting patients to the potentially damaging effects of chemo...well, that IS revolutionary. And their marketing efforts needed to reflect that. However, Kiyatec's founders are marketing-naïve scientists. We needed to help them generate national awareness with a new journal ad that would appeal to neurosurgeons, medical oncologists, and neuropathologists. We started with the concept that every body is different, so a one-size-fits-all approach just doesn't make sense for cancer treatment. This bold journal ad seamlessly marries a powerful patient image with a dynamic representation of a cancer cell, both linked by the universal language of "MOA" (Mechanism of Action). It's the epitome of personalized healthcare, putting the patient at the heart of it all.